Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working

Rukshana Shroff1, Constantinos J Stefanidis, Varvara Askiti

  • 1Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. rukshana.shroff@gosh.nhs.uk

Insights

Encapsulating peritoneal sclerosis (EPS) in children on peritoneal dialysis (PD) is as common as in adults, but less deadly. Longer dialysis, frequent peritonitis, and ultrafiltration failure signal potential EPS in pediatric PD patients.

Area of Science:

  • Pediatric Nephrology
  • Gastroenterology
  • Dialysis Complications

Background:

  • Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of peritoneal dialysis (PD).
  • Limited data exists on pediatric EPS, necessitating further investigation into its prevalence and outcomes in children.
  • This study addresses the scarcity of information regarding EPS in pediatric PD patients.

Purpose of the Study:

  • To determine the prevalence of EPS in children undergoing PD.
  • To identify risk factors associated with EPS development in pediatric patients.
  • To describe the clinical outcomes and mortality associated with pediatric EPS.

Main Methods:

  • A 10-year survey of chronic PD patients from January 2001 to December 2010 across 14 European dialysis units.
  • Inclusion of pediatric patients on chronic PD.
  • Data collection on EPS diagnosis, patient demographics, dialysis vintage, peritonitis rates, and clinical outcomes.

Main Results:

  • The prevalence of EPS in European children on PD was 1.5% (8.7 per 1000 patient-years).
  • Patients with EPS had significantly longer PD vintage (median 5.9 years) and higher peritonitis rates compared to non-EPS patients.
  • Ultrafiltration failure and bowel obstruction were common presenting symptoms, with 3 deaths and 8 patients on hemodialysis at follow-up.

Conclusions:

  • The prevalence of pediatric EPS is comparable to adults, but mortality is significantly lower.
  • A high index of suspicion for EPS is crucial in children with prolonged dialysis, high peritonitis rates, and ultrafiltration failure.
  • Early diagnosis and management are vital for improving outcomes in pediatric EPS.
Abstract

Related Concept Videos

Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...